Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 672 entries
View as:

A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT01843127 Org: User:
Start: 04/30/13 End: 09/30/13 Due: 09/30/14

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02405442 Org: User:
Start: 04/30/15 End: 12/22/16 Due: 12/22/17

Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

Phase: N/A Priority: Normal
NCT ID: NCT02592057 Org: User:
Start: 11/30/15 End: 04/23/18 Due: 04/23/19

Phase 3 Study of Sofosbuvir and Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT01497366 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03912831 Org: User:
Start: 04/30/19 End: 02/18/22 Due: 02/18/23

Study of Obeldesivir in Children and Adolescents With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05996744 Org: User:
Start: 12/26/23 End: 02/23/24 Due: 02/23/25

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01909804 Org: User:
Start: 06/30/13 End: 08/31/14 Due: 08/31/15

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03036839 Org: User:
Start: 06/27/17 End: 02/14/19 Due: 02/14/20

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

Phase: N/A Priority: Normal
NCT ID: NCT03110380 Org: User:
Start: 06/12/17 End: 02/10/21 Due: 02/10/22

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT01923311 Org: User:
Start: 08/26/13 End: 11/03/17 Due: 11/03/18

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

Phase: N/A Priority: Normal
NCT ID: NCT00615810 Org: User:
Start: 03/31/08 End: 01/31/10 Due: 01/31/11

Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00285428 Org: User:
Start: 09/30/04 End: 10/31/07 Due: 10/31/08

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00077948 Org: User:
Start: 07/31/03 End: 06/30/05 Due: 06/30/06

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06167317 Org: User:
Start: 01/09/24 End: 09/30/28 Due: 09/30/29

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT02242045 Org: User:
Start: 10/01/14 End: 10/17/17 Due: 10/17/18

Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

Phase: N/A Priority: Normal
NCT ID: NCT05718700 Org: User:
Start: 02/07/23 End: 11/30/27 Due: 11/30/28

A Study of GS-5423 and GS-2872 in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT05729568 Org: User:
Start: 05/15/23 End: 12/31/29 Due: 12/31/30

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Phase: N/A Priority: Normal
NCT ID: NCT02457611 Org: User:
Start: 06/30/15 End: 01/31/16 Due: 01/31/17

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03558139 Org: User:
Start: 05/23/18 End: 12/03/20 Due: 12/03/21

A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

Phase: N/A Priority: Normal
NCT ID: NCT01801293 Org: User:
Start: 03/31/13 End: 04/30/13 Due: 04/30/14

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002415 Org: User:
Start: - End: - Due: -

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

Phase: N/A Priority: Normal
NCT ID: NCT02613871 Org: User:
Start: 12/22/15 End: 11/07/18 Due: 11/07/19

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01362231 Org: User:
Start: 12/31/10 End: 12/31/12 Due: 12/31/13

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Phase: N/A Priority: Normal
NCT ID: NCT01604850 Org: User:
Start: 06/30/12 End: 05/31/13 Due: 05/31/14

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01826981 Org: User:
Start: 04/30/13 End: 05/31/15 Due: 05/31/16